UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Body fluid management using BCM improves kidney function’
by Park Gi-taek
2017-09-12 08:26
Healthcare benefits for immune checkpoint inhibitor Tecentrqi, unclear
by Park Gi-taek
2017-08-30 10:17
When can we hear about the conquest of liver cancer?
by Park Gi-taek
2017-08-29 07:00
‘Let's protect patients until complete cure of hepatitis B comes’
by Park Gi-taek
2017-08-28 10:46
Drugmakers cut entertainment expense due to anticorruption law
by Park Gi-taek
2017-08-25 16:27
라인
‘Moon Jae-in care’ keeps industry busy weighing bottom lines
by Park Gi-taek
2017-08-11 13:42
New osteoporosis therapy causes curiosity about drug price
by Park Gi-taek
2017-08-07 14:42
‘Neither handouts nor patient complaints give insurance benefits to expensive drugs’
by Park Gi-taek
2017-07-24 20:28
CEOs of foreign pharmaceuticals don't seem to regard Korean employees as colleagues
by Park Gi-taek
2017-07-13 18:20
Castleman’s disease patients suffer from high drug prices
by Park Gi-taek
2017-07-11 17:00
라인
First patient resistant to Viread found in Korea
by Park Gi-taek
2017-06-26 13:40
Is personalized cancer treatment using NGS unavailable in Korea?
by Park Gi-taek
2017-06-22 18:19
‘Korean version of NOAC guidelines may come out before long’
by Park Gi-taek
2017-06-20 17:52
‘Early diagnosis necessary for treating rare Gaucher's disease’
by Park Gi-taek
2017-06-19 20:22
Introduction of DAA changed treatment of Hepatitis C
by Park Gi-taek
2017-06-07 16:43
라인
Gilead’s new hepatitis B therapy in controversy due to side effects
by Park Gi-taek
2017-05-31 17:04
Gilead Sciences keeps on rolling in Korea: Why?
by Park Gi-taek
2017-05-11 14:52
Can Jardiance threaten Forxiga's dominance in treating diabetes?
by Park Gi-taek
2017-05-04 13:30
‘We must move beyond completely curing Hepatitis C to eradicating it’
by Park Gi-taek
2017-04-18 14:47
Will post-mass infection anti-HCV measures prove to be sufficient?
by Park Gi-taek
2017-04-17 16:49
-
1
2
3
4
5
6
7
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top